Oppenheimer: Catalyst Health Solutions Announces Outsourcing Agreement
According to a research report published this morning by Oppenheimer, Catalyst Health Solutions Inc. (NASDAQ: CHSI) announced last night that it would be the exclusive PBM provider for Regence Rx.
Oppenheimer further commented in the report, “Regence Rx is a not-for-profit PBM located in the Pacific Northwest managing pharmacy benefits for over 1.2 million members of Regence Health Plans. While financial terms of the deal were not disclosed, we believe the announcement should reassure investors that the company's Invest Now program is yielding results. Assuming the contract is structured under a transparent pricing model, we estimate the deal could contribute as much as $0.10/share for CHSI in 2013.”
Catalyst Health Solutions closed yesterday at $61.09.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.